Please login to the form below

Not currently logged in
Email:
Password:

Panenza given go ahead in France

Sanofi-aventis' non-adjuvanted influenza A (H1N1) 2009 vaccine, Panenza, has received marketing authorisation for use in France

Sanofi-aventis' non-adjuvanted influenza A (H1N1) 2009 vaccine, Panenza, has received marketing authorisation for use in France.

The French drug agency Afssaps (Agence Française de Sécurité Sanitaire des Produits de Santé) has granted marketing authorisation for Panenza, thereby making the vaccine available to French health authorities.

Panenza is produced at the Sanofi Pasteur vaccines division facility in Val de Reuil, France.

Sanofi Pasteur's president and chief executive officer, Wayne Pisano, said: "Registration and on-schedule delivery of A(H1N1) 2009 influenza vaccines remain high priorities for Sanofi Pasteur to help support authorities' pandemic immunisation efforts and address this public health challenge.

"The marketing authorisation approval for Panenza represents a key regulatory step, as this non-adjuvanted vaccine could initially be selected in national immunisation programmes to protect specific populations in some European countries," Pisano added.

Sanofi Pasteur has filed a decentralised marketing authorisation application for Panenza vaccine in six European Union countries: Belgium, France, Germany, Italy, Luxembourg and Spain.

16th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics